Eurycomanone from Eurycoma longifolia Jack roots regulates dopamine secretion via transsynaptic GABA signalling in differentiated SH-SY5Y human neuroblastoma cells: a transcriptomic study
Related Experiment Video
Updated: Feb 27, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Jing-Jie Ang1, Pooi-Fong Wong2, Naveen Kumar Hawala Shivashekaregowda3
1School of Medicine, Faculty of Health and Medical Sciences, Taylor's University, 1, Jalan Taylor's, Subang Jaya, 47500, Selangor, Malaysia.
Abstract:
PURPOSE: Eurycomanone (EN), a quassinoid from Eurycoma longifolia Jack (EL) has been previously shown to promote dopamine secretion from differentiated SH-SY5Y human neuroblastoma cells but the mechanism that underpins this property is unknown. This study sought to investigate transcriptomic changes associated with the dopamine secretory property of the isolated EN in the differentiated SH-SY5Y cells. METHODS: Differential gene expression (DGE) in EN-responsive SH-SY5Y cells was investigated by microarray analysis. RESULTS: Previous work demonstrated that EN stimulated dopamine secretion in a dose-dependent manner at 5, 10 and 15 µM, followed by reduction in secretion at higher concentration (20 to 25 µM). At 15 µM, EN significantly increased dopamine secretion compared to the positive control, clorgyline hydrochloride (10 µM, p < 0.05). Microarray analysis showed that gene expression changes by EN and the bioactive fraction Fr2 across varying concentrations closely corresponded to the observed dopamine secretion profiles. Accordingly, 15 µM EN, which elicited the most pronounced differential gene expression (DGE) was selected for pathway enrichment analysis. Subsequent qPCR validation suggested that EN modulates transsynaptic signalling between GABA-producing and differentiated SH-SY5Y cells. In silico molecular docking study further indicated that EN may activate cannabinoid CB1 and muscarinic M3 receptors, potentially suppressing inhibitory GABA release and thereby facilitating dopamine secretion in differentiated cells. The resultant increase in dopaminergic excitability by EN may be counter-regulated through AMPK-dependent autophagy. CONCLUSION: These transcriptomic findings support a neurobiochemical role of EN in promoting dopaminergic activity, offering a mechanistic basic for the traditional use of EL roots as a male sexual booster.
More Related Videos
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Neurochemical Transmission: Sites of Drug Action
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

